A5040260035- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Epilepsy research and treatment
- Neuroscience and Neural Engineering
- Genetic Neurodegenerative Diseases
- Functional Brain Connectivity Studies
- Botulinum Toxin and Related Neurological Disorders
- Pain Mechanisms and Treatments
- Radiomics and Machine Learning in Medical Imaging
- Transcranial Magnetic Stimulation Studies
- EEG and Brain-Computer Interfaces
- Glioma Diagnosis and Treatment
- Traumatic Brain Injury and Neurovascular Disturbances
- Neuroscience and Neuropharmacology Research
- Dementia and Cognitive Impairment Research
- Sarcoma Diagnosis and Treatment
- Tumors and Oncological Cases
- Meningioma and schwannoma management
- Medical Imaging Techniques and Applications
- Disaster Response and Management
- Restless Legs Syndrome Research
- Teratomas and Epidermoid Cysts
- Photoreceptor and optogenetics research
- Brain Tumor Detection and Classification
- COVID-19 and healthcare impacts
University of California, Los Angeles
2023-2024
University of Milan
2021-2024
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2021-2024
Ospedale Maggiore
2022-2024
Istituti di Ricovero e Cura a Carattere Scientifico
2024
Olive View-UCLA Medical Center
2023
Neuroimaging differentiation of glioblastoma, primary central nervous system lymphoma (PCNSL) and solitary brain metastasis (BM) remains challenging in specific cases showing similar appearances or atypical features. Overall, advanced MRI protocols have high diagnostic reliability, but their limited worldwide availability, coupled with the overlapping neuroimaging features among tumor subgroups, represent significant drawbacks entail disparities planning management these oncological...
Background: Epilepsy is a widespread neurologic disorder and almost one-third of patients suffer from drug-resistant epilepsy (DRE). Neuromodulation targeting the centromediannucleus thalamus (CM) has been showing promising results for with generalized DRE who are not surgical candidates. Recently, effect CM- deep brain stimulation (DBS) in was investigated Electrical Stimulation Thalamus Lennox–Gastaut phenotype (ESTEL) trial, monocentric randomized-controlled study. The same authors...
Object: To investigate those parameters affecting early and follow-up functional outcomes in patients undergoing resection of meningiomas to design a dedicated predictive score, the Milan Bio(metric)-Surgical Score (MBSS) is hereby presented. Methods: Patients transcranial surgery for intracranial were included. The most significant regression analyses implemented patient stratification score validated by testing its classification consistency with clinical−radiological grading scale (CRGS),...
(1) Background: Neuroimaging differentiation of glioblastoma, primary central nervous system lymphoma (PCNSL) and solitary brain metastasis (BM) represents a diagnostic therapeutic challenge in neurosurgical practice, expanding the burden care exposing patients to additional risks related further invasive procedures treatment delays. In addition, atypical cases overlapping features have not been entirely addressed by modern research. The aim this study was validate previously designed...
OBJECTIVE Essential tremor (ET) is the most common movement disorder. Deep brain stimulation (DBS) targeting ventral intermediate nucleus (VIM) known to improve symptoms in patients with medication-resistant ET. However, clinical effectiveness of VIM-DBS may vary, and other targets have been proposed. The authors aimed investigate whether same anatomical structure responsible for control both immediately after at later follow-up evaluations. METHODS Of 68 electrodes from 41 ET, mapped...
Dystonia is common in Parkinson disease patients, affecting about 30% of them. Bilateral subthalamic nucleus deep brain stimulation (DBS) can sometimes lead to dystonia, but this relationship not well understood. Our aim was provide a better understanding dystonia's causes and its connection DBS.
To characterize ictal EEG change in the centromedian (CM) and anterior nucleus (AN) of thalamus, using stereoelectroencephalography (SEEG) recordings.
Abstract Background Deep Brain Stimulation (DBS) is a promising treatment for medication-refractory neuropathic pain. The ventral posteromedial (VPM) and posterolateral (VPL) nuclei of the thalamus are popular targets facial limb pain, respectively. While intraoperative testing used to adjust targeting patient-specific pain locations, better understanding thalamic somatotopy may improve specific body regions including individual trigeminal territories, face, arm, leg. Objectives To elucidate...